BMO Capital analyst Evan Seigerman downgrades Incyte (NASDAQ:INCY) from Market Perform to Underperform and lowers the price target from $52 to $48.
BMO Capital Downgrades Incyte to Underperform, Lowers Price Target to $48
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.